ENDO INTERNATIONAL PLC (ENDP)

C3i partners with Paladin Labs Inc. to offer Canadian clinicians a complimentary testing service to detect T315I mutation

/PRNewswire/ - C3i Center Inc and Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP), have partnered to launch a complimentary clinical...

C3i partners with Paladin Labs Inc. to offer Canadian clinicians a complimentary testing service to detect T315I mutation

/CNW/ - C3i Center Inc and Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP), have partnered to launch a complimentary clinical testing...

TJX Companies (TJX) Stock Moves on Mixed Q2 Earnings

TJX Companies (TJX) stock is on the move Wednesday after releasing mixed results in its earnings report for Q2 of fiscal 2023.

What Is Going on With Endo International (ENDP) Stock Today?

Endo International (ENDP) stock is taking a beating on Wednesday after the company filed for bankruptcy protection and revealed an RSA.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We've got the news behind the biggest pre-market stock movers for Wednesday morning that traders need to know about this morning!

Drugmaker Endo Files for Bankrupty Over Debt, US Opioid Litigation

Drug manufacturer Endo International Plc filed for bankruptcy after being overwhelmed by litigation, including claims that it profited by helping fuel the US opioid epidemic.

Endo Enters Into Restructuring Support Agreement with Senior Secured Debtholders to Strengthen Financial Position and Advance Ongoing Business Transformation

/PRNewswire/ -- Endo International plc (NASDAQ: ENDP) ("Endo" or the "Company") today announced that it has entered into a restructuring support agreement...

Endo Creditors Eye Plan for Drugmaker’s Sale Through Bankruptcy

Endo International (ENDP) Stock Plunges Amid Bankruptcy Warning

Endo International reported a top- and bottom-line beat for its second quarter, but ENDP stock is plunging on bankruptcy fears.

ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS

DUBLIN, Aug. 9, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the second-quarter ended June 30, ...

New Drug Filing for Cenobamate Accepted for Review in Canada and Israel

/PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd. announced that Health Canada has accepted Paladin Labs Inc.'s filing of a New Drug Submission (NDS) for...

ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS

/CNW/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the second-quarter ended June 30, 2022. SECOND-QUARTER FINANCIAL...

ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS

/PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the second-quarter ended June 30, 2022. SECOND-QUARTER FINANCIAL...

Paladin Labs Announces Health Canada's Filing Acceptance of Cenobamate Tablets as an Adjunctive Therapy for the Management of Partial-Onset Seizures in Adults with Epilepsy

/CNW/ -- Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP), announced today that Health Canada has accepted its New Drug Submission...